Xtant Medical Holdings, Inc. (NYSE:XTNT) Q4 2024 Results Conference Call March 6, 2025 4:30 PM ET
Company Participants
Brett Maas – Hayden IR
Sean Browne – President & Chief Executive Officer
Scott Neils – Chief Financial Officer
Conference Call Participants
Chase Knickerbocker – Craig-Hallum
Operator
Good day, everyone, and welcome to the Xtant Medical Fourth Quarter and Year-End 2024 Earnings. At this time, all participants have been placed on a listen-only mode. [Operator Instructions]
It is now my pleasure to turn the floor over to your host, Brett Maas with Hayden IR. Sir, the floor is yours.
Brett Maas
Thank you, operator. Joining me today is Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer. Today’s call is being webcast and will be posted on the company’s website for playback.
During the course of this call, management may make certain forward-looking statements, regarding future events and the company’s expected future performance. These forward-looking statements reflect Xtant’s current perspective on existing trends and information and can be identified with such words as expect, plan, will, may, anticipate, believes, should, and tends, in other words, with similar meaning.
Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including those noted in the risk factors section of the company’s annual report on Form 10-K filed this afternoon with the SEC and in subsequent SEC reports and press releases.
Actual results may differ materially. The company’s financial results, press release, and today’s discussion include certain non-GAAP financial measures. Please refer to the non-GAAP and GAAP reconciliations, which appear in our press release and are otherwise available on our website. Note that our Form 8-K filed with our financial results press release provide a detailed narrative that describes our use of such measures.
For the benefit
Read the full article here